The Central Commission for Discipline Inspection met to set the tone for medical anti-corruption

Medicine Network January 26 - The Central Commission for Discipline Inspection met to deploy the 2021 mandate, medical anti-corruption is still the focus of the Central Commission for Discipline Inspection meeting, the deployment of the 2021 task January 25, the People's Daily, the 01st edition published the "19th Central Commission for Discipline Inspection of the Communist Party of China, the fifth plenary meeting communique."
the central commission's task of deploying 2021, it includes: continuing to clean up corruption and injustice around the masses, promoting social equity and justice, and safeguarding the legitimate rights and interests of the masses.
Strengthen supervision and inspection of the implementation of policies and measures to benefit the rich and the people and promote common prosperity, strengthen supervision over the consolidation of the achievements of the "four no-pick" policies, ensure effective convergence with rural revitalization, continue to address corruption and style issues in the fields of education and medical care, old-age social security, ecological and environmental protection, safe production, food and drug safety, law enforcement and justice, resolutely punish the "umbrella" involved in black-related evils, and improve the governance mechanism for issues that harm the interests of the masses in the field of people's livelihood.
it is understood that since the 2019 Third Plenary Session of the 19th Central Commission for Discipline Inspection proposed "to carry out special rectification in the field of people's livelihood", the issue of medical corruption has become one of the key issues of concern to the plenary session of the Central Commission for Discipline Inspection.
January 13, 2020, the Fourth Plenary Session of the 19th Central Commission for Discipline Inspection also explicitly mentioned that "we should resolutely investigate and punish collusion between medical institutions and outside the fraud and insurance fraud."
We can find that for the problem of medical corruption, the national level requires from "solution", to "resolute investigation and punishment", and now "continuous correction", it can be seen that the country's fight against medical corruption is growing, more and more determined.
, 2021 as the "14th Five-Year Plan" of the opening year, with the introduction and improvement of various policies, the medical anti-corruption storm will come more violent.
anti-corruption is still the focus since 2020, the Central Commission for Discipline Inspection, the National Supervisory Commission network has repeatedly published medical personnel were investigated, drug rebates and other related content of the article, directly referring to medical corruption.
incomplete statistics, in the past 10 years, there have been thousands of cases involving pharmaceutical bribery, often involving pharmaceutical companies, pharmaceutical representatives, doctors.
recent cases of corruption in the medical system have been manifested in the collusion between leading cadres and staff of medical institutions and suppliers, forming a chain of corrupt interests.
, unreasonable drug use, unreasonable inspection, unreasonable use of high-value medical supplies and other phenomena occur.
some medical personnel use the right to prescribe in their hands to "bill the bill", the use of medical equipment, drug supplies procurement and other medical and health resources for profit and even job crimes.
Some "first-in-command" hospitals as "private territory", in addition to "first-hand", the proportion of key positions involved in the case is higher, such as mastering drugs, medical equipment and other procurement resources at the county level or above hospitals and township hospitals, departments or department heads.
under a series of strict inspections, the vast majority of hospitals and medical staff have taken the initiative to shut out non-compliant pharmaceutical companies.
And from the Central Commission for Discipline Inspection to adjust the medical anti-corruption, the National Health and Safety Commission to strictly check drug rebates, to the State Health Insurance Administration with a large amount of procurement to squeeze drug prices, to the pharmaceutical industry tax verification, more and more pharmaceutical companies have been timely transformation, from the past rely on high drug pricing, channel space to pull sales of traditional drug marketing methods, into professional products and academic services to promote the product model.
we also look forward to, under a series of rectification, the pharmaceutical industry environment can continue to be purified, the real origin, play its greater value and contribution.